Safety, Tolerability, and Immunogenicity of the Novel Antituberculous Vaccine RUTI: Randomized, Placebo-Controlled Phase II Clinical Trial in Patients with Latent Tuberculosis Infection
出版年份 2014 全文链接
标题
Safety, Tolerability, and Immunogenicity of the Novel Antituberculous Vaccine RUTI: Randomized, Placebo-Controlled Phase II Clinical Trial in Patients with Latent Tuberculosis Infection
作者
关键词
Vaccines, Immune response, Tuberculosis, Mycobacterium tuberculosis, Adverse events, Vaccination and immunization, Abscesses, Antigens
出版物
PLoS One
Volume 9, Issue 2, Pages e89612
出版商
Public Library of Science (PLoS)
发表日期
2014-02-27
DOI
10.1371/journal.pone.0089612
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The candidate tuberculosis vaccine Mtb72F/AS02A: Tolerability and immunogenicity in humans
- (2014) Kenneth Von Eschen et al. Human vaccines & immunotherapeutics
- Adipose tissue biology and HIV-infection
- (2011) Marta Giralt et al. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- The multistage vaccine H56 boosts the effects of BCG to protect cynomolgus macaques against active tuberculosis and reactivation of latent Mycobacterium tuberculosis infection
- (2011) Philana Ling Lin et al. JOURNAL OF CLINICAL INVESTIGATION
- Ag85B–ESAT-6 adjuvanted with IC31® promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in volunteers with previous BCG vaccination or tuberculosis infection
- (2011) Jaap T. van Dissel et al. VACCINE
- Revisiting the Natural History of Tuberculosis
- (2010) Pere-Joan Cardona ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS
- Ag85B–ESAT-6 adjuvanted with IC31® promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in naïve human volunteers
- (2010) Jaap T. van Dissel et al. VACCINE
- Influence of a Vaccination Schedule on Viral Load Rebound and Immune Responses in Successfully Treated HIV-Infected Patients
- (2009) Pedro Castro et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Safety and Immunogenicity of a New Tuberculosis Vaccine, MVA85A, inMycobacterium tuberculosis–infected Individuals
- (2009) Clare R. Sander et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- A Dynamic Reinfection Hypothesis of Latent Tuberculosis Infection
- (2009) P.-J. Cardona INFECTION
- Double-blind, randomized, placebo-controlled Phase I Clinical Trial of the therapeutical antituberculous vaccine RUTI®
- (2009) C. Vilaplana et al. VACCINE
- Induction of a Specific Strong Polyantigenic Cellular Immune Response after Short-Term Chemotherapy Controls Bacillary Reactivation in Murine and Guinea Pig Experimental Models of Tuberculosis
- (2008) E. Guirado et al. Clinical and Vaccine Immunology
- A New Recombinant Bacille Calmette‐Guérin Vaccine Safely Induces Significantly Enhanced Tuberculosis‐Specific Immunity in Human Volunteers
- (2008) Daniel F. Hoft et al. JOURNAL OF INFECTIOUS DISEASES
- Safety and Immunogenicity of a New Tuberculosis Vaccine, MVA85A, in Healthy Adults in South Africa
- (2008) Tony Hawkridge et al. JOURNAL OF INFECTIOUS DISEASES
- Immunological Outcomes of New Tuberculosis Vaccine Trials: WHO Panel Recommendations
- (2008) Willem A Hanekom et al. PLOS MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now